How many stocks are there of Avicanna?
The current number of stocks of Avicanna is 84.71 M undefined.
Avicanna Stocks 2025
Avicanna Stocks
84.71 M
Ticker
AVCN.TO
ISIN
CA05368K1003
WKN
A2PN04
In 2025, Avicanna had 84.71 M outstanding stocks, a 0% change from the 84.71 M stocks in the previous year.
The Avicanna Stocks history
| YEAR | NUMBER OF STOCKS (undefined CAD) |
|---|---|
| 2026e | 84.71 |
| 2025e | 84.71 |
| 2024e | 84.71 |
| 2023 | 84.71 |
| 2022 | 59.17 |
| 2021 | 41.29 |
| 2020 | 29.4 |
| 2019 | 20.05 |
| 2018 | 22.29 |
| 2017 | 22.29 |
| 2016 | 22.29 |
Avicanna shares outstanding CA05368K1003 · A2PN04
The number of shares was Avicanna in 2024 — This indicates how many shares 84.708 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Avicanna earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Avicanna's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Avicanna’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Avicanna's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2016 | 22.29 M Aktien |
| 2017 | 22.29 M Aktien |
| 2018 | 22.29 M Aktien |
| 2019 | 20.05 M Aktien |
| 2020 | 29.4 M Aktien |
| 2021 | 41.29 M Aktien |
| 2022 | 59.17 M Aktien |
| 2023 | 84.71 M Aktien |
| 2024e | 84.71 M Aktien |
| 2025e | 84.71 M Aktien |
| 2026e | 84.71 M Aktien |
Avicanna Aktienanalyse
What does Avicanna do?
Avicanna Inc is a Canadian biopharmaceutical company specializing in the research, development, and manufacturing of medical marijuana products. The company was founded in 2016 by its president and CEO Aras Azadian, who has extensive experience in the pharmaceutical and biotechnology industry. The company is based in Toronto, Canada and also operates in Colombia and Switzerland. Avicanna has several subsidiaries, including Santa Marta Golden Hemp, which operates its cultivation business in Colombia. Avicanna's business model is focused on producing medical marijuana products that have better efficacy and tolerability than conventional products. The company uses a specialized process called PhytoVista™ to isolate and extract the active ingredients in plant extracts. Avicanna operates in various sectors, including the manufacturing and marketing of medical marijuana products, research and development of effective medical treatments, and collaboration with healthcare facilities and government agencies in marijuana regulation. The company offers a variety of products, including different types of hemp oil, CBD products, and pharmaceutical products such as Rho PhytoTM and Pura EarthTM. These products all share the common approach of providing patients with better, more effective, and tolerable treatment options. Rho PhytoTM is a patented medical marijuana product by Avicanna, derived from a specific cannabis strain called ACMPR. This product is approved in Canada and available as an oral solution and syringe. Rho PhytoTM is specifically tailored to meet the needs of patients with neurodegenerative diseases and has proven to be effective. Pura EarthTM is a herbal remedy derived from the medical marijuana plant and is intended to be used as an alternative medicine for pain and inflammation. In addition to manufacturing medical marijuana products, the company also conducts intensive research and development to develop medications based on synthetic cannabinoids. These substances have the potential to help patients with various conditions such as multiple sclerosis, epilepsy, and tumor diseases. Avicanna also has partnerships with various healthcare facilities and government agencies to advance the regulation of medical marijuana and ensure the safety and efficacy of these products. In summary, Avicanna is an innovative biopharmaceutical company specializing in the manufacturing and marketing of medical marijuana products. The company serves various areas within the marijuana industry, including the production of medical products, research and development, and regulation of marijuana products. With an extensive product range and a strong research and development department, Avicanna is well positioned to continue growing and developing more innovative products in the coming years. Avicanna ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Avicanna's Shares Outstanding
Avicanna's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Avicanna’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Avicanna’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Avicanna’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Avicanna stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Avicanna are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Avicanna evolved in recent years?
The number of shares of Avicanna has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Avicanna as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Avicanna?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Avicanna pay?
Over the past 12 months, Avicanna paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Avicanna is expected to pay a dividend of 0 CAD.
What is the dividend yield of Avicanna?
The current dividend yield of Avicanna is .
When does Avicanna pay dividends?
Avicanna pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Avicanna?
Avicanna paid dividends every year for the past 0 years.
What is the dividend of Avicanna?
For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Avicanna located?
Avicanna is assigned to the 'Health' sector.
Wann musste ich die Aktien von Avicanna kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Avicanna from 4/11/2025 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 4/11/2025.
When did Avicanna pay the last dividend?
The last dividend was paid out on 4/11/2025.
What was the dividend of Avicanna in the year 2024?
In the year 2024, Avicanna distributed 0 CAD as dividends.
In which currency does Avicanna pay out the dividend?
The dividends of Avicanna are distributed in CAD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Avicanna stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Avicanna
Our stock analysis for Avicanna Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Avicanna Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
